The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis

• Published in: Drug and alcohol dependence Vol. 174; pp. 80 - 90
• Main Authors: Goldenberg, Matthew, Reid, Mark William, IsHak, Waguih William, Danovitch, Itai
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.05.2017; Elsevier Science Ltd
• Subjects: Analgesics - therapeutic use; Bias; Cannabinoids; Cannabis; Clinical outcomes; Clinical trials; Cross-Sectional Studies; Data processing; Data quality; Design; Disorders; Evidence-based medicine; Guidelines; Health services; Health status; HIV; HIV Infections - drug therapy; HRQOL; Human immunodeficiency virus; Humans; Inflammatory Bowel Diseases - drug therapy; Literature reviews; Marijuana; Medical conditions; Medical marijuana; Medical Marijuana - therapeutic use; Meta-analysis; Multiple sclerosis; Multiple Sclerosis - drug therapy; Observational studies; Pain; Pain - drug therapy; Patients; Policy making; Psychiatry; QOL; Quality of care; Quality of Life; Selection criteria; Systematic review; Therapeutics; Quality of Life; Marijuana; HRQOL; Cannabis; Cannabinoids; QOL; Quality of life
• ISSN: 0376-8716; 1879-0046
• DOI: 10.1016/j.drugalcdep.2016.12.030

Highlights • Using cannabis/cannabinoids to treat medical conditions is increasingly common. • The impact on health-related quality of life (HRQoL) remains unclear. • This systematic review and meta-analysis of studies evaluates the impact on HRQoL. • Studies showing a positive impact on HRQoL involved subjects with pain symptoms. • Cannabis studies showed a positive impact on HRQoL than cannabinoids studies.